Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,812 | 40,285 | 24,459 | 29,866 | 27,201 |
| Marketable Securities | 15,545 | 18,377 | 33,747 | 51,776 | 61,965 |
| Receivables | 20,819 | 29,366 | 40,320 | 15,525 | 17,198 |
| Inventories | 10,782 | 11,077 | 9,118 | 7,116 | 6,218 |
| TOTAL | $100,925 | $106,972 | $115,903 | $110,440 | $120,521 |
| Non-Current Assets | |||||
| PPE Net | 215 | 294 | 857 | 1,694 | 1,832 |
| Intangibles | 14,413 | 14,681 | 14,949 | 0 | 0 |
| Other Non-Current Assets | 1,538 | 1,665 | 2,570 | 3,475 | 5,648 |
| TOTAL | $16,166 | $16,640 | $18,376 | $5,169 | $7,480 |
| Total Assets | $117,091 | $123,612 | $134,279 | $115,609 | $128,001 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,240 | 6,295 | 22,508 | 2,721 | 2,155 |
| Accrued Expenses | 12,565 | 12,601 | 16,574 | 16,347 | 16,738 |
| Other current liabilities | 19,384 | 19,708 | 17,142 | 5,912 | 11,823 |
| TOTAL | $44,023 | $45,518 | $65,211 | $47,265 | $54,955 |
| Non-Current Liabilities | |||||
| Long Term Debt | 59,574 | 59,484 | 39,448 | 39,468 | 29,835 |
| Deferred Revenues | 1,355 | 1,369 | 1,369 | 1,369 | 1,543 |
| Other Non-Current Liabilities | 41,609 | 42,867 | 43,236 | 48,710 | 46,888 |
| TOTAL | $101,183 | $102,351 | $82,684 | $88,178 | $76,723 |
| Total Liabilities | $145,206 | $147,869 | $147,895 | $135,443 | $131,678 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,436 | 17,367 | 17,365 | 17,284 | 17,284 |
| Common Shares | 175 | 174 | 174 | 173 | 173 |
| Retained earnings | -1,402,595 | -1,395,995 | -1,382,459 | -1,383,860 | -1,364,823 |
| Other shareholders' equity | -25 | -27 | -153 | -286 | -438 |
| TOTAL | $-28,115 | $-24,257 | $-13,616 | $-19,834 | $-3,677 |
| Total Liabilities And Equity | $117,091 | $123,612 | $134,279 | $115,609 | $128,001 |